Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Burden of respiratory syncytial virus infection in older and high-risk adults: a systematic review and meta-analysis of the evidence from developed countries
Jonathan S. Nguyen‐Van‐Tam, Maureen A. O’Leary, Emily T. Martin, et al.
European Respiratory Review (2022) Vol. 31, Iss. 166, pp. 220105-220105
Open Access | Times Cited: 115

Showing 26-50 of 115 citing articles:

Respiratory syncytial virus: challenges in diagnosis and impact on the elderly: Recommendations from a multidisciplinary panel
Lessandra Michelin, Nancy Bellei, Marcelo Ferreira da Costa Gomes, et al.
Human Vaccines & Immunotherapeutics (2024) Vol. 20, Iss. 1
Open Access | Times Cited: 5
Burden of disease of respiratory syncytial virus in older adults and adults considered at high risk of severe infection
Elissa M. Abrams, Paméla Doyon-Plourde, Phaedra Davis, et al.
Canada Communicable Disease Report (2025) Vol. 51, Iss. 1, pp. 26-34
Open Access
An mRNA-Based Respiratory Syncytial Virus Vaccine Elicits Strong Neutralizing Antibody Responses and Protects Rodents Without Vaccine-Associated Enhanced Respiratory Disease
Jianglong Li, Haiyan Long, Shaoyi Chen, et al.
Vaccines (2025) Vol. 13, Iss. 1, pp. 52-52
Open Access
Laboratory confirmation of respiratory syncytial virus infection is not associated with increased risk of death in adults with acute respiratory illness
Jeffrey A. Kline, Robert D. Welch, Christopher Kabrhel, et al.
Open Forum Infectious Diseases (2025) Vol. 12, Iss. 2
Open Access
Preventing RSV Infection in Children: Current Passive Immunizations and Vaccine Development
Pius I. Babawale, Iván Martínez-Espinoza, Andrew Mitchell, et al.
Pathogens (2025) Vol. 14, Iss. 2, pp. 104-104
Open Access
Adult vaccinations against respiratory infections
Antoní Torres, Catia Cillóniz, Marta Aldea, et al.
Expert Review of Anti-infective Therapy (2025)
Closed Access
Trends in Proportions of Respiratory Syncytial Virus Infections Among Reported Respiratory Tract Infection Cases in Children Aged 0 to 5 Years in Western Pacific and Southeast Asia Regions: A Systematic Review and Meta‐Analysis
Sangshin Park, Hyelan Lee, Jung Yoon Park, et al.
Influenza and Other Respiratory Viruses (2025) Vol. 19, Iss. 2
Open Access
Update on vaccines against respiratory syncytial virus (RSV): A narrative review
José Gutierrez-Rodriguez, Jaime Rodríguez-Salazar, Francisco José Tarazona‐Santabalbina
Revista Española de Geriatría y Gerontología (2025) Vol. 60, Iss. 2, pp. 101630-101630
Closed Access
Mexican Interdisciplinary Consensus on the Diagnosis and Preventive Measures for Respiratory Syncytial Virus Infections
Rosa María Wong‐Chew, Daniel E. Noyola, Fortino Solórzano‐Santos, et al.
Archives of Medical Research (2025) Vol. 56, Iss. 4, pp. 103183-103183
Open Access
Burden of Respiratory Syncytial Virus Disease in Adults with Asthma and Chronic Obstructive Pulmonary Disease: A Systematic Literature Review
Yolanda Penders, Guy Brusselle, Ann R. Falsey, et al.
Current Allergy and Asthma Reports (2025) Vol. 25, Iss. 1
Open Access
Perceived benefits, information, vaccination history, and conspiracy beliefs as significant determinants of RSV vaccine acceptance among Arab seniors
Malik Sallam, Kholoud Al-Mahzoum, Zainab Mansour Yousef, et al.
Therapeutic Advances in Vaccines and Immunotherapy (2025) Vol. 13
Open Access
Exploring the Contribution of TLR7 to Sex-Based Disparities in Respiratory Syncytial Virus (RSV)-Induced Inflammation and Immunity
Mark A. Miles, Thomas D. Huttmann, Stella Liong, et al.
Viruses (2025) Vol. 17, Iss. 3, pp. 428-428
Open Access
Immunogenicity and Safety of the Bivalent Respiratory Syncytial Virus Prefusion F Subunit Vaccine in Immunocompromised or Renally Impaired Adults
Natalia E. Castillo Almeida, Lalitha Parameswaran, Elliot DeHaan, et al.
Vaccines (2025) Vol. 13, Iss. 3, pp. 328-328
Open Access
Age-related changes in the immune system and challenges for the development of age-specific vaccines
Mark Doherty, Birgit Weinberger, Arnaud M. Didierlaurent, et al.
Annals of Medicine (2025) Vol. 57, Iss. 1
Open Access
Burden of respiratory syncytial virus in adults in the United Kingdom: A systematic literature review and gap analysis
Tom Wilkinson, Steph Beaver, Malcolm Macartney, et al.
Influenza and Other Respiratory Viruses (2023) Vol. 17, Iss. 9
Open Access | Times Cited: 13
Characteristics and outcomes of patients hospitalized for infection with influenza, SARS-CoV-2 or respiratory syncytial virus in the season 2022/2023 in a large German primary care centre
Carolin Quarg, Rudolf A. Jörres, Stefan Engelhardt, et al.
European journal of medical research (2023) Vol. 28, Iss. 1
Open Access | Times Cited: 13
Prevalence and Etiology of Community- and Hospital-Acquired Pneumonia in Saudi Arabia and Their Antimicrobial Susceptibility Patterns: A Systematic Review
Mohammed Kanan Alshammari, Mzoun Abdulaziz Alotaibi, Ahad Sanad AlOtaibi, et al.
Medicina (2023) Vol. 59, Iss. 4, pp. 760-760
Open Access | Times Cited: 12
Safety, Immunogenicity, and Regimen Selection of Ad26.RSV.preF–Based Vaccine Combinations: A Randomized, Double-blind, Placebo-Controlled, Phase 1/2a Study
Christy Comeaux, Stephan Bart, Arangassery Rosemary Bastian, et al.
The Journal of Infectious Diseases (2023) Vol. 229, Iss. 1, pp. 19-29
Open Access | Times Cited: 12
Respiratory syncytial virus incidence and typing in the last six seasons in the north of Spain (Asturias). Genetic characterization during the SARS‐CoV‐2 pandemic
Susana Rojo‐Alba, Zulema Pérez Martínez, José Marı́a González-Alba, et al.
Journal of Medical Virology (2024) Vol. 96, Iss. 3
Closed Access | Times Cited: 4
Epidemiology and Disease Burden of Respiratory Syncytial Virus Infection in Adults
Taeeun Kim, Sang‐Ho Choi
Infection and Chemotherapy (2024) Vol. 56, Iss. 1, pp. 1-1
Open Access | Times Cited: 4
Whole-Genome Sequencing and Genetic Diversity of Human Respiratory Syncytial Virus in Patients with Influenza-Like Illness in Sicily (Italy) from 2017 to 2023
Fabio Tramuto, Carmelo Massimo Maida, Giulia Randazzo, et al.
Viruses (2024) Vol. 16, Iss. 6, pp. 851-851
Open Access | Times Cited: 4
Association between underlying conditions, multimorbidity, and COVID-19 vaccination status of adults aged ≥80 years old in Beijing, China
Yuping Duan, Luodan Suo, Xiaomei Li, et al.
Vaccine (2025) Vol. 47, pp. 126677-126677
Open Access
Healthcare Resource Utilization and Economic Outcomes of RSV-Hospitalized Patients Aged ≥ 60 Years: A Retrospective Cohort Study
Anna Puggina, Melania Dovizio, Alexander Domnich, et al.
Diseases (2025) Vol. 13, Iss. 3, pp. 68-68
Open Access
Hospitalisation due to respiratory syncytial virus in a population-based cohort of older adults in Spain, 2016/17 to 2019/20
Noelia Vera-Punzano, Camino Trobajo‐Sanmartín, Ana Navascués, et al.
Eurosurveillance (2025) Vol. 30, Iss. 10
Open Access
Demographics and clinical burden of disease among RSV-hospitalized older adults in Italy: A retrospective cohort study
Anna Puggina, Melania Dovizio, Alexander Domnich, et al.
Human Vaccines & Immunotherapeutics (2025) Vol. 21, Iss. 1
Open Access

Scroll to top